Show simple item record

dc.contributor.authorHubner, Richard A
dc.contributor.authorCubillo, A
dc.contributor.authorBlanc, J
dc.contributor.authorMelisi, D
dc.contributor.authorVon Hoff, D
dc.contributor.authorWang-Gillam, A
dc.contributor.authorChen, L
dc.contributor.authorBecker, C
dc.contributor.authorMamlouk, K
dc.contributor.authorBelanger, B
dc.contributor.authorYang, Y
dc.contributor.authorde Jong, F
dc.contributor.authorSiveke, J
dc.date.accessioned2017-05-01T20:23:56Z
dc.date.available2017-05-01T20:23:56Z
dc.date.issued2016-06
dc.identifier.citationO-004 - Effects of nal-IRI (MM-398) +/- 5-fluorouracil on quality of life (QoL) of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine based therapy: results from NAPOLI-1. 2016, 27(suppl 2):ii119 Annals of Oncologyen
dc.identifier.issn1569-8041
dc.identifier.issn0923-7534
dc.identifier.doi10.1093/annonc/mdw198.04
dc.identifier.urihttp://hdl.handle.net/10541/620301
dc.language.isoenen
dc.relation.urlhttps://academic.oup.com/annonc/article/2475056/O-004<breaken
dc.rightsArchived with thanks to Annals of Oncologyen
dc.titleO-004 - Effects of nal-IRI (MM-398) +/- 5-fluorouracil on quality of life (QoL) of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine based therapy: results from NAPOLI-1.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentThe Christie NHS Foundation Trust, Manchesteren
dc.identifier.journalAnnals of Oncologyen


This item appears in the following Collection(s)

Show simple item record